NCT02815566View on ClinicalTrials.gov

Bone Health in Aging HIV Infected Women

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 12, 2017

Primary Completion Date

February 25, 2021

Study Completion Date

February 25, 2021

Conditions
OsteoporosisHIVMenopause
Interventions
DRUG

tenofovir-alafenamide-emtricitabine

comparison of tenofovir-emtricitabine and tenofovir-alafenamide-emtricitabine on bone mineral density

DRUG

tenofovir-emtricitabine

comparison of tenofovir-emtricitabine and tenofovir-alafenamide-emtricitabine on bone mineral density

Trial Locations (7)

20127

Ospedale San Raffaele, Milan

41124

Università degli Studi di Modena e Reggio Emilia, Modena

V6Z 2C7

Vancouver ID Research and Care Centre, Vancouver

L8S 1A4

Hamilton Health Sciences, Hamilton

M5G 2C4

University Health Network, Toronto

H4A 3J1

McGill University Health Centre, Montreal

G1V 4G2

CHU de Québec-Université Laval, Québec

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

University of Modena and Reggio Emilia

OTHER

collaborator

San Raffaele University Hospital, Italy

OTHER

collaborator

Gilead Sciences

INDUSTRY

collaborator

CIHR Canadian HIV Trials Network

NETWORK

lead

University Health Network, Toronto

OTHER